Growth Metrics

Biomarin Pharmaceutical (BMRN) Change in Intangibles (2018 - 2025)

Biomarin Pharmaceutical's Change in Intangibles history spans 8 years, with the latest figure at $2.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Intangibles rose 207.93% year-over-year to $2.4 million, compared with a TTM value of $7.9 million through Dec 2025, down 33.83%, and an annual FY2025 reading of $7.9 million, down 33.83% over the prior year.
  • Change in Intangibles for Q4 2025 was $2.4 million at Biomarin Pharmaceutical, down from $5.3 million in the prior quarter.
  • The five-year high for Change in Intangibles was $15.6 million in Q4 2021, with the low at $266000.0 in Q2 2025.
  • Average Change in Intangibles over 5 years is $3.4 million, with a median of $1.9 million recorded in 2022.
  • Year-over-year, Change in Intangibles crashed 95.7% in 2022 and then soared 2480.65% in 2024.
  • Tracing BMRN's Change in Intangibles over 5 years: stood at $15.6 million in 2021, then crashed by 95.7% to $671000.0 in 2022, then soared by 1059.31% to $7.8 million in 2023, then plummeted by 90.11% to $769000.0 in 2024, then skyrocketed by 207.93% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Change in Intangibles are $2.4 million (Q4 2025), $5.3 million (Q3 2025), and $266000.0 (Q2 2025).